Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × iniparib × Clear all

NCT01161836 2013-09-24

An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors